Cardiovascular diseases are still one of the most frequent causes of death. Since the heart muscle cannot regenerate itself, the tissue is usually remodeled leading to impaired heart function in the long term. Many patients who have survived a heart attack suffer from cardiac insufficiency years later…

Angew Chem Int Ed Engl. 2020: Christian Ottmann, Madita Wolter, Dario Valenti, Peter J Cossar, Laura M. Levy, Stanimira Hristeva, Thorsten Genski, Torsten Hoffmann, Luc Brunsveld, Dimitrios Tzalis,

Taros EVP Youri R. Mesmoudi was interviewed in the current Issue of CHEManager´s Section Chemistry & Life Sciences on “From Idea to Product – the principle of an extended workbench accelerates innovation in chemistry”

Due to current situation with the spread of the Sars-CoV-2 (“Coronavirus”) we want to share with you the latest information on how Taros Chemicals have prepared for both, the protection of our employees and partners’ health and the uninterrupted continuation of our chemistry and discovery services to our clients…

Drug Discovery Strategic Summit highlights the advances in current and emerging hot targets and technologies, as well as target validation strategies for the discovery and development from biologics to small molecules. DDSS is custom designed to provide an exceptional platform to unfold…

The ECP is a rendezvous of chemistry, green chemistry, biotechnology, industrial biotechnology, nanotechnology, engineering, digitization, analytics, apparatuses, devices: Here you will find new products from good old chemistry as well as new products based on green and clean methods…

SelectBIO Organ-on-a-Chip, Tissue-on-a-Chip & Organoids Europe 2020 focuses on an important and expanding field wherein cells are being assembled using Microfluidics and Lab-on-a-Chip technologies in a functionally-relevant manner. These clusters of “assembled cells” have…

This edition will continue the tradition established for these symposia of covering advances in drug discovery in major therapeutic areas, including the treatment of bacterial and viral infections, diseases related to the CNS, heart disease, fibrotic diseases and cancer…

Ahead of Oxford Global’s R&D Series Drug Discovery Virtual on 29-30 July 2020 in Berlin, Germany, Oxford Global spoke to Torsten Hoffmann of Taros Chemicals about his work in Pharmaceutical R&D and the opportunities and challenges in Drug Discovery…

I3-STM dealt with a new, tailor-made immunotherapeutic approach using small antibody mimetics synthesized for the therapy of triple-negative breast cancer (TNBC), which is still insufficiently treated with the classic methods. These drugs consist of components that stimulate the immune system and…